Category: Healthcare innovation

Digital Health Technologies in Europe: New European Commission Report Highlights Opportunities and Challenges

Digital health technologies in Europe are a key pillar in transforming care systems, as highlighted in the new European Commission report (published in 2026), titled “Observatory for Digital Health Technologies in Europe”. The report, prepared for the Directorate-General CONNECT (DG CNECT) by Capgemini Invent and IDC, provides a comprehensive overview of the EU27 digital health market, analyzing both the technology ecosystem and its economic impact.

The report is structured in three main sections. The first focuses on the creation of the Digital Health Technologies Observatory, a strategic tool for monitoring adoption, innovation, and investment in the sector. The second part presents the economic analysis of five selected technologies, while the third contains conclusions and policy recommendations.

The analysis draws on extensive data, including pan-European surveys of healthcare providers and technology companies, expert interviews, mapping of hundreds of providers, and analysis of tens of thousands of investment records. The findings depict a rapidly growing yet fragmented digital health market in Europe.

Artificial intelligence plays a central role in this transformation, with 94% of healthcare providers already adopting or planning to integrate it. Technologies such as Clinical Decision Support Systems (CDSS), automated medical imaging analysis, and digital mental health platforms are highlighted as particularly important for improving care quality and enhancing health system efficiency.

The economic benefits are substantial. CDSS are estimated to enable savings of up to €252 billion over a decade, while automated medical imaging analysis could save up to €192 billion. Similarly, digital mental health platforms support early intervention and reduce the burden on healthcare services, providing significant social and economic benefits.

The report also identifies critical challenges, such as market fragmentation, interoperability issues, and dependence on non-EU providers in strategic areas. Additionally, issues related to digital skills, regulatory frameworks, and equitable access continue to affect the widespread adoption of these technologies.

To address these challenges, the report recommends measures such as strengthening interoperability, supporting small and medium-sized enterprises, promoting innovation in cutting-edge fields (such as AI and genomics), and integrating principles of sustainability, accessibility, and equity.

The positioning of digital health technologies in Europe as a key pillar for the future of care systems is closely linked with initiatives developed at the national level. In this context, Kapa3 invests in digital tools that enhance information, accessibility, and empowerment of oncology patients, such as the “Myrto” Health Navigator. You can read more about it here.

As Europe seeks to build a more resilient and inclusive health system, leveraging digital technologies emerges as a decisive factor in improving patient quality of life and the effectiveness of healthcare services.

Sources:

Text/Adaptation: Ifiyenia Anastasiou for Kapa3

World Cancer Day: United by Our Uniqueness

Every year on 4 February, World Cancer Day invites us to reflect on one of the greatest challenges of modern public health.

The goal is not only to confront cancer as a disease, but to face it with knowledge, empathy and shared responsibility. Because cancer touches millions of lives in countless ways, yet it does not define who we are. We are more than a diagnosis, more than a number.

World Cancer Day was established in 2000, following the World Summit Against Cancer for the New Millennium in Paris. It is a core element of the Paris Charter Against Cancer — a global commitment to advancing research, prevention, patient care, awareness and international mobilisation. Since then, the day has served as a reminder that addressing cancer requires long-term vision, cooperation and consistency.

This year’s message, “United by Unique”, highlights a fundamental truth: cancer is not only a medical event.

It is a deeply personal experience. Behind every diagnosis lies a unique human story — stories of fear and loss, but also of resilience, care, love and healing. Every story counts.

Cancer Today: Facts and Challenges

Cancer remains one of the most significant public health challenges in Europe and in Greece. Data from international and European organisations underline not only the scale of the disease, but also the persistent inequalities in prevention, early detection and access to care.

In Europe, approximately 2.7 million new cancer diagnoses are recorded each year, with around 1.3 million deaths, while the economic burden exceeds €93 billion annually. In Greece, cancer is the second leading cause of death, affecting thousands of families and carrying profound social and psychological consequences.

Progress, Prevention and Hope

At the same time, scientific progress offers well-founded reasons for optimism.

Prevention and early detection remain decisive factors. Screening programmes, vaccination, healthy lifestyle choices and access to reliable information can significantly reduce the risk of certain cancers and improve treatment outcomes. In this context, knowledge is not merely information — it is power and a fundamental right.

Advances in cancer management are equally important. Personalised medicine, targeted therapies, immunotherapy and improved management of treatment side effects contribute not only to increased survival rates, but also to a better quality of life for people living with and beyond cancer. Information and education are key tools for both prevention and empowerment.

Mental health plays a crucial role as well. Diagnosis and treatment are often accompanied by anxiety, fear, sadness and emotional exhaustion — affecting not only patients, but also their caregivers. Psychosocial support, counselling services and empowerment groups are essential components of holistic cancer care, helping to preserve dignity and quality of life.

Information, research and mental health care are core pillars of modern cancer management. Indicatively, you may explore the following Kapa3 articles:

Empowerment and Action

World Cancer Day is not just a day of awareness. It is a call to action:

  • to speak openly about prevention and our health,

  • to support people living with cancer and their caregivers,

  • to seek reliable information and evidence-based sources,

  • to advocate for equal access to care and psychological support,

  • to remember that no one should face cancer alone.

Because our strength lies in solidarity — and in respecting the uniqueness of every individual.

United by our uniqueness.

References:

World Health Organization (WHO) – Cancer
https://www.who.int/health-topics/cancer

International Agency for Research on Cancer (IARC)
https://www.iarc.who.int

Union for International Cancer Control (UICC) – World Cancer Day
https://www.worldcancerday.org

European Commission – Europe’s Beating Cancer Plan
https://health.ec.europa.eu/eu-policy/health-strategies/europes-beating-cancer-plan_en

European Cancer Information System (ECIS)
https://ecis.jrc.ec.europa.eu

Hellenic Statistical Authority (ELSTAT) – Health Data
https://www.statistics.gr/en/statistics/-/publication/SHE15/

Hellenic National Public Health Organization (EODY) – Cancer & Public Health
https://eody.gov.gr/

Greek Ministry of Health – Prevention & Screening
https://www.moh.gov.gr/articles/prevention-screening

Text/adaptation: Ifiyenia Anastasiou for Kapa3

Gut Microbiota: A Hidden Ally in Cancer Treatment

Our gut is home to trillions of microorganisms, collectively called the gut microbiota, which play a crucial role in digestion, immunity, and overall health. Excitingly, research is revealing that these tiny residents can also influence the effectiveness of cancer treatments—from immunotherapy to chemotherapy and beyond. Understanding this connection opens new possibilities for more personalized and effective cancer care.

Boosting Immunotherapy through Gut Microbes

Innovative therapies like CAR-T cell therapy, immune checkpoint inhibitors (ICIs), oncolytic viruses (OVs), and CpG-oligonucleotide immunotherapy have transformed cancer treatment in recent years. Studies show that the composition of gut microbiota can affect how well patients respond to these therapies.

For instance, certain bacteria—such as Ruminococcus, Faecalibacterium, and Akkermansia—are linked to better CAR-T outcomes, while broad-spectrum antibiotics may reduce therapy effectiveness. Similarly, gut microbes can enhance responses to ICIs by stimulating immune cells that attack tumors. OVs, which work by killing cancer cells and activating the immune system, also benefit from a healthy gut microbiota. Even CpG-based therapies are more effective when gut microbes activate immune pathways.

In short, a balanced gut microbiota can help “turn cold tumors into hot tumors,” making them more responsive to modern immunotherapies.

Gut Microbes and Traditional Treatments

Gut microbiota also affects chemotherapy and radiotherapy. Some microbes can influence drug metabolism, improving efficacy or reducing side effects. For example, bacteria like Enterococcus hirae and Barnesiella intestinihominis enhance the response to cyclophosphamide, a common chemotherapy drug, by activating immune cells.

On the other hand, disruptions in gut microbiota—often caused by antibiotics or radiation—can increase treatment toxicity, leading to issues like intestinal inflammation or mucositis. Promising strategies like fecal microbiota transplantation (FMT) and certain probiotics have shown potential to restore gut balance, reduce side effects, and improve overall outcomes.

Complementary Approaches: TCM and Probiotics

Traditional medicine can also benefit from gut microbes. Traditional Chinese Medicine (TCM) compounds, when processed by gut bacteria, can transform into more potent anti-cancer agents. Certain TCM herbs and formulas can also promote beneficial bacteria while suppressing harmful ones.

Similarly, probiotics, prebiotics, and synbiotics—foods or supplements that nourish or contain helpful bacteria—can support cancer treatment by strengthening gut immunity, reducing inflammation, and enhancing drug effectiveness. For example, in combination with chemotherapy or immunotherapy, synbiotics have been shown to reduce treatment-related side effects while boosting therapeutic benefits.

Emerging Strategies: Engineering the Microbiota

Beyond diet and probiotics, scientists are developing targeted microbiota interventions to fight cancer more precisely. These include:

  • Engineered microbes, designed to deliver anti-cancer agents directly to tumors.
  • Phage therapy, using viruses that selectively kill harmful bacteria.
  • Nanomedicine and OMVs (outer membrane vesicles), which can deliver drugs or immune-stimulating molecules to tumors while sparing healthy microbes.

These cutting-edge approaches are still under study, but they demonstrate the incredible potential of harnessing gut microbes to improve therapy effectiveness and reduce toxicity.

Looking Ahead: Precision Medicine and Microbiota

The future of cancer treatment may increasingly involve personalized microbiota strategies. By analyzing an individual’s gut bacteria and metabolites, clinicians could tailor therapies to maximize efficacy and minimize side effects. Combining microbiota profiling with multi-omics analysis, AI, and big data could allow doctors to predict treatment response and guide interventions in a way that was unimaginable just a decade ago.

While challenges remain—including differences in individual microbiotas, safety considerations, and regulatory hurdles—the potential is enormous. Gut microbiota represents a promising frontier in precision oncology, offering hope for more effective, safer, and individualized cancer care.

Read the full article here

Text/Adaptation: Ifiyenia Anastasiou for Kapa3

Kapa3 at the Patients Summit 2025: A strong voice for cancer patients and their families

The Patients Summit 2025—the annual nationwide meeting organized by the Hellenic Patients Association—was successfully completed with great success. The event has become the leading forum for dialogue and collaboration among patient organizations across Greece. This year’s conference brought together representatives of patient associations, healthcare professionals, and policymakers to strengthen the voice of patients and shape a more humane, participatory, and effective healthcare system.

Participants exchanged experiences, presented best practices, and discussed key issues such as sustainability of patient associations, access to innovative treatments, the use of digital health tools, and patient empowerment in decision-making.

Through thematic panels and interactive workshops, the event highlighted the need for cooperation, transparency, and the use of data to drive targeted solutions with real social impact.

Kapa3 actively participated in the Summit, representing cancer patients and their families. A highlight of its presence was its contribution to the Strategic Workshop: “How do we measure our value?”, where Kapa3 presented its approach and operational philosophy on data collection and utilization as a tool for developing innovative initiatives.

For Kapa3, data collection is a key process in understanding the real needs of its beneficiaries. As emphasized during the session, data analysis—conducted in collaboration with the organization’s biostatistician, Mr. Konstantinos Tzanas—helps Kapa3 design targeted and evidence-based strategies. Continuous evaluation by patients themselves enables the adaptation of services and the development of innovative solutions that have a tangible, positive impact on their lives.

Kapa3’s presence at the Patients Summit 2025 underscored the importance of collaboration, scientific evidence, and collective action. The organization remains committed to amplifying the voice of cancer patients through knowledge, innovation, and transparency—values that can truly transform the patient experience and contribute to a fairer, more humane healthcare system for all.